News | January 17, 2024
Parexel collaborates with Japanese Foundation for cancer research
Collaboration streamlines patient access to oncology clinical trials
Collaboration streamlines patient access to oncology clinical trials
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
Subscribe To Our Newsletter & Stay Updated
